Non-PVC Fluid Path Port Access Infusion Set With Slit Septum Injection Site
by Kawasumi Laboratories Co., Ltd.
510(k) K964117
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK964117 | Date14 Mar 1997 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- LJT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5965
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 26 Sep 2026
The Non-PVC Fluid Path Port Access Infusion Set is a medical device designed to access implanted medication ports. It facilitates the delivery of medications into the patient's system via an intravascular route.
This device is classified as an implanted, subcutaneous, intravascular port and catheter under FDA regulation number 880.5965. It has received FDA 510(k) clearance for use in general hospital settings.
Other devices from Kawasumi Laboratories Co., Ltd.
Questions
AI-generated answers, 26 Sep 2026
What is the primary purpose of this infusion set?
This device is designed to access implanted medication ports, allowing for the delivery of medications into a patient's system via an intravascular route.
What regulatory classification does this device fall under?
This device is classified as an implanted, subcutaneous, intravascular port and catheter under FDA regulation number 880.5965 and has received FDA 510(k) clearance for use in general hospital settings.
What are the key features of this infusion set?
The set features a non-PVC fluid path and includes a slit septum injection site, which is specifically engineered to facilitate reliable access to implanted ports.